PDL BIOPHARMA, INC.;PDL BIOPHARMA; INC.;DANA-FARBER CANCER INSTITUTE, INC.
发明人:
AFAR, DANIEL,ANDERSON, KENNETH C.,TAI, YU-TZU
申请号：
CA2660356
公开号：
CA2660356C
申请日:
2007.08.07
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
Composition suitable for treating multiple myeloma in a subject, comprising a therapeutically effective amount of HuLuc63, a therapeutically effective amount of lenalidomide and/or bortezomib, and a pharmaceutically acceptable carrier, wherein said composition is capable of beeing administered in a single or multiple dose regimen.
